Improving Financial Health

Investment in technology and innovation FY17 FY18 FY19 FY20 FY21 New and key scaling products revenue (US$m) Capex 399 431 439 487 422 US$m 678 Capex % 9% 9% 9% 9% 8% of revenue Capital investment breakdown (%) Product Development 20% 24% 28% 33% 41% Infrastructure 32% 31% 34% 31% 25% 108 Data 48% 45% 38% 36% 34% 39 Experian Public 213 359 537 FY17 FY18 FY19 FY20 FY21 FY17 FY18 FY19 FY20 FY21 Consumer: ID Works Lead generation Brazil consumer B2B: PowerCurve suite Ascend CrossCore Health, new products Auto, new products experian.

View entire presentation